Arrowhead Pharmaceuticals, Inc. (ARWR) stock

ARWRNasdaqPharmaceutical PreparationsFiscal year ends September 30

Financials through Q4 FY2026, quarter ended Sep 30, 2026Last filing: 10-K on Nov 12, 2026Score 3/30

$47.78+0.63 (+1.34%)

Close on Nov 13, 2026Market cap $6.75BP/E –Yield –

Arrowhead Pharmaceuticals gross margin

Gross margin is gross profit as a percentage of revenue.

Arrowhead Pharmaceuticals has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Parsed from the XBRL in Arrowhead Pharmaceuticals's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Nov 17, 2011
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing